ConductScience.org, home

Paper5639737

Antifibrinolytic therapy for intracranial aneurysms.

Mullan S and 1 other. J Neurosurg, 1968. Cited by 127 papers, by iCite.

Cite this record

ConductScience Library. Antifibrinolytic therapy for intracranial aneurysms. Papers, record 5639737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5639737

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antifibrinolytic therapy for intracranial aneurysms.
PubMed
Journal
J Neurosurg
PubMed
Year
1968
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
127
iCite
Revised in PubMed
2013-11-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mullan SS
2Dawley JJ

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AminocaproatesMajor topic
Intracranial AneurysmMajor topic
Subarachnoid HemorrhageMajor topic
Humans

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 127 citations.

PMIDTitleJournalYearIn PapersSource
36350005Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage.Cochrane Database Syst Rev2022https://conductscience.org/library/papers/36350005PubMed
29305756On Aneurysmal Rupture and Rerupture.Neurocrit Care2018https://conductscience.org/library/papers/29305756PubMed
18818887Perioperative use of recombinant factor VII to prevent intraoperative aneurysm rupture in high risk patients: a preliminary safety evaluation.Neurocrit Care2009https://conductscience.org/library/papers/18818887PubMed
18730851The Use of AMICAR(R) in Subarachnoid Hemorrhage.Calif Med1972https://conductscience.org/library/papers/18730851PubMed
7376944Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.Acta Neurochir (Wien)1980https://conductscience.org/library/papers/7376944PubMed
7229645Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.J Neurol Neurosurg Psychiatry1981https://conductscience.org/library/papers/7229645PubMed
7048863Antifibrinolytic treatment in subarachnoid haemorrhage: present state.Acta Neurochir (Wien)1982https://conductscience.org/library/papers/7048863PubMed
7031186Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage.J Neurol Neurosurg Psychiatry1981https://conductscience.org/library/papers/7031186PubMed
7000850Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.J Clin Pathol Suppl (R Coll Pathol)1980https://conductscience.org/library/papers/7000850PubMed
5576904Ruptured intracranial aneurysms.Proc R Soc Med1971https://conductscience.org/library/papers/5576904PubMed
5576488Use of an anti-fibrinolytic agent (tranexamic acid) in the management of ruptured intracranial aneurysms.Postgrad Med J1971https://conductscience.org/library/papers/5576488PubMed
3546604Antifibrinolytic agents in subarachnoid haemorrhage.J Neurol1987https://conductscience.org/library/papers/3546604PubMed
3177035Rebleeding, ischaemia and hydrocephalus following anti-fibrinolytic treatment for ruptured cerebral aneurysms: a retrospective clinical study.Acta Neurochir (Wien)1988https://conductscience.org/library/papers/3177035PubMed
2407050Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.Acta Neurochir (Wien)1990https://conductscience.org/library/papers/2407050PubMed
2205078Fibrinolytic activity after subarachnoid haemorrhage and the effect of tranexamic acid.Acta Neurochir (Wien)1990https://conductscience.org/library/papers/2205078PubMed
932226Fibrin-fibrinogen degradation products in cerebrospinal fluid.J Clin Pathol1976https://conductscience.org/library/papers/932226PubMed
878925Fibrinolytic activity in the walls of cerebral saccular aneurysms.Acta Neurochir (Wien)1977https://conductscience.org/library/papers/878925PubMed
649775Coagulation and fibrinolytic activity of cerebrospinal fluid.J Clin Pathol1978https://conductscience.org/library/papers/649775PubMed
452972Early intracranial operations for ruptured aneurysms.Acta Neurochir (Wien)1979https://conductscience.org/library/papers/452972PubMed
346153Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?Br Med J1978https://conductscience.org/library/papers/346153PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5639737

GET https://conductscience.org/api/papers/v1/5639737/cited_by?page=2